Ireland-based clinical trial technology provider Teckro has raised $25m in a new financing round led by Founders Fund to support its international expansion and drive product development.

The financing round, which brings the company’s total funding to $43m, was also joined by Sands Capital Ventures, Bill Maris’ Section 32 venture fund and Borealis Ventures.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Founded in 2015, Teckro provides a machine learning platform that is said to make trials fast, accurate, simpler and more transparent for doctors, researchers and patients.

On its website, Teckro CEO Gary Hughes said: “We challenge ourselves to find the best, most forward-looking way to deliver successful trials.

“What happens before the data is recorded has a much bigger impact on your trial’s outcome than any number of post-hoc remedial actions or strategies. In an industry focused on retrospective activities, it just makes sense to look at things differently.”

Teckro platform is currently used by approximately 10,000 clients across 80 countries, including pharma majors and small biotech companies.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Headquartered in Limerick, Teckro also has operations in Dublin, Ireland and Nashville, US. The company employs a total of approximately 100 people.

Reuters noted that testing in humans is the most expensive stage of drug development. The costs keep increasing as the development becomes more complex.

Teckro intends to make the process simpler by making some of the paperwork digital and enabling quick retrieval of information, the news agency added.

Hughes was quoted as saying: “It’s really about providing answers to day-to-day questions any doctor and nurse may have in the context of a clinical trial in an instant.”